Anti-Apoptotic Effect of Tax: An NF-κB Path or a CREB Way?
Abstract
:1. Introduction
2. NF-κB Pathway
3. PI3K/Akt Pathway
4. CREB Activation
5. Conclusions
Acknowledgments
Conflict of Interest
References and Notes
- Hinuma, Y.; Nagata, K.; Hanaoka, M.; Nakai, M.; Matsumoto, T.; Kinoshita, K.I.; Shirakawa, S.; Miyoshi, I. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. U. S. A. 1981, 78, 6476–6480. [Google Scholar] [CrossRef] [PubMed]
- Poiesz, B.J.; Ruscetti, F.W.; Gazdar, A.F.; Bunn, P.A.; Minna, J.D.; Gallo, R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 1980, 77, 7415–7419. [Google Scholar] [CrossRef] [PubMed]
- Gessain, A.; Barin, F.; Vernant, J.C.; Gout, O.; Maurs, L.; Calender, A.; de The, G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2, 407–410. [Google Scholar] [CrossRef]
- Uchiyama, T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu. Rev. Immunol. 1997, 15, 15–37. [Google Scholar] [CrossRef] [PubMed]
- Hasegawa, H.; Sawa, H.; Lewis, M.J.; Orba, Y.; Sheehy, N.; Yamamoto, Y.; Ichinohe, T.; Tsunetsugu-Yokota, Y.; Katano, H.; Takahashi, H.; et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 2006, 12, 466–472. [Google Scholar] [CrossRef] [PubMed]
- Grassmann, R.; Dengler, C.; Muller-Fleckenstein, I.; Fleckenstein, B.; McGuire, K.; Dokhelar, M.C.; Sodroski, J.G.; Haseltine, W.A. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc. Natl. Acad. Sci. U. S. A. 1989, 86, 3351–3355. [Google Scholar] [CrossRef]
- Robek, M.D.; Ratner, L. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 1999, 73, 4856–4865. [Google Scholar] [CrossRef]
- Smith, M.R.; Greene, W.C. Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein. Virology 1992, 187, 316–320. [Google Scholar] [CrossRef]
- Gitlin, S.D.; Lindholm, P.F.; Marriott, S.J.; Brady, J.N. Transdominant human T-cell lymphotropic virus type I TAX1 mutant that fails to localize to the nucleus. J. Virol. 1991, 65, 2612–2621. [Google Scholar] [CrossRef]
- Semmes, O.J.; Jeang, K.T. Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles. J. Virol. 1996, 70, 6347–6357. [Google Scholar] [CrossRef]
- Fryrear, K.A.; Durkin, S.S.; Gupta, S.K.; Tiedebohl, J.B.; Semmes, O.J. Dimerization and a novel Tax speckled structure localization signal are required for Tax nuclear localization. J. Virol. 2009, 83, 5339–5352. [Google Scholar] [CrossRef]
- Burton, M.; Upadhyaya, C.D.; Maier, B.; Hope, T.J.; Semmes, O.J. Human T-cell leukemia virus type 1 Tax shuttles between functionally discrete subcellular targets. J. Virol. 2000, 74, 2351–2364. [Google Scholar] [CrossRef]
- Gatza, M.L.; Marriott, S.J. Genotoxic stress and cellular stress alter the subcellular distribution of human T-cell leukemia virus type 1 tax through a CRM1-dependent mechanism. J. Virol. 2006, 80, 6657–6668. [Google Scholar] [CrossRef]
- Alefantis, T.; Jain, P.; Ahuja, J.; Mostoller, K.; Wigdahl, B. HTLV-1 Tax nucleocytoplasmic shuttling, interaction with the secretory pathway, extracellular signaling, and implications for neurologic disease. J. Biomed. Sci. 2005, 12, 961–974. [Google Scholar] [CrossRef]
- Nejmeddine, M.; Barnard, A.L.; Tanaka, Y.; Taylor, G.P.; Bangham, C.R. Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 2005, 280, 29653–29660. [Google Scholar] [CrossRef]
- Felber, B.K.; Paskalis, H.; Kleinman-Ewing, C.; Wong-Staal, F.; Pavlakis, G.N. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985, 229, 675–679. [Google Scholar] [CrossRef]
- Sodroski, J.G.; Rosen, C.A.; Haseltine, W.A. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 1984, 225, 381–385. [Google Scholar] [CrossRef]
- Fujisawa, J.; Seiki, M.; Kiyokawa, T.; Yoshida, M. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 2277–2281. [Google Scholar] [CrossRef]
- Jin, D.Y.; Spencer, F.; Jeang, K.T. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 1998, 93, 81–91. [Google Scholar] [CrossRef]
- Schmitt, I.; Rosin, O.; Rohwer, P.; Gossen, M.; Grassmann, R. Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J. Virol. 1998, 72, 633–640. [Google Scholar] [CrossRef]
- Neuveut, C.; Jeang, K.T. HTLV-I Tax and cell cycle progression. Prog. Cell Cycle Res. 2000, 4, 157–162. [Google Scholar] [PubMed]
- Suzuki, T.; Yoshida, M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16Ink4a and counteracts its inhibitory activity to CDK4. Leukemia 1997, 11, 14–16. [Google Scholar] [CrossRef] [PubMed]
- Wu, K.; Bottazzi, M.E.; de la Fuente, C.; Deng, L.; Gitlin, S.D.; Maddukuri, A.; Dadgar, S.; Li, H.; Vertes, A.; Pumfery, A.; Kashanchi, F. Protein profile of tax-associated complexes. J. Biol. Chem. 2004, 279, 495–508. [Google Scholar] [CrossRef] [PubMed]
- Miyake, H.; Suzuki, T.; Hirai, H.; Yoshida, M. Trans-activator Tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome. Virology 1999, 253, 155–161. [Google Scholar] [CrossRef]
- Chieco-Bianchi, L.; Saggioro, D.; Del Mistro, A.; Montaldo, A.; Majone, F.; Levis, A.G. Chromosome damage induced in cord blood T-lymphocytes infected in vitro by HTLV-I. Leukemia 1988, 2, S223–S232. [Google Scholar]
- Lemoine, F.J.; Marriott, S.J. Genomic instability driven by the human T-cell leukemia virus type I (HTLV-I) oncoprotein, Tax. Oncogene 2002, 21, 7230–7234. [Google Scholar] [CrossRef]
- Haoudi, A.; Daniels, R.C.; Wong, E.; Kupfer, G.; Semmes, O.J. Human T-cell leukemia virus-I tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response. J. Biol. Chem. 2003, 278, 37736–37744. [Google Scholar] [CrossRef]
- Marriott, S.J.; Semmes, O.J. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005, 24, 5986–5995. [Google Scholar] [CrossRef]
- Chandhasin, C.; Ducu, R.I.; Berkovich, E.; Kastan, M.B.; Marriott, S.J. Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response. J. Virol. 2008, 82, 6952–6961. [Google Scholar] [CrossRef]
- Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57–70. [Google Scholar] [CrossRef]
- Zhang, N.; Hartig, H.; Dzhagalov, I.; Draper, D.; He, Y.W. The role of apoptosis in the development and function of T lymphocytes. Cell Res. 2005, 15, 749–769. [Google Scholar] [CrossRef]
- Taylor, R.C.; Cullen, S.P.; Martin, S.J. Apoptosis: Controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9, 231–241. [Google Scholar] [CrossRef]
- Chen, X.; Zachar, V.; Zdravkovic, M.; Guo, M.; Ebbesen, P.; Liu, X. Role of the Fas/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator. J. Gen. Virol. 1997, 78, 3277–3285. [Google Scholar] [CrossRef]
- Chlichlia, K.; Moldenhauer, G.; Daniel, P.T.; Busslinger, M.; Gazzolo, L.; Schirrmacher, V.; Khazaie, K. Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene 1995, 10, 269–277. [Google Scholar]
- Los, M.; Khazaie, K.; Schulze-Osthoff, K.; Baeuerle, P.A.; Schirrmacher, V.; Chlichlia, K. Human T cell leukemia virus-I (HTLV-I) Tax-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state. J. Immunol. 1998, 161, 3050–3055. [Google Scholar] [CrossRef]
- Nicot, C.; Harrod, R. Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 tax protein. Mol. Cell. Biol. 2000, 20, 8580–8589. [Google Scholar] [CrossRef]
- Rivera-Walsh, I.; Waterfield, M.; Xiao, G.; Fong, A.; Sun, S.C. NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death. J. Biol. Chem. 2001, 276, 40385–40388. [Google Scholar] [CrossRef]
- Kao, S.Y.; Lemoine, F.J.; Marriott, S.J. p53-independent induction of apoptosis by the HTLV-I tax protein following UV irradiation. Virology 2001, 291, 292–298. [Google Scholar] [CrossRef]
- Chlichlia, K.; Los, M.; Schulze-Osthoff, K.; Gazzolo, L.; Schirrmacher, V.; Khazaie, K. Redox events in HTLV-1 tax-induced apoptotic T-cell death. Antioxid. Redox Signal. 2002, 4, 471–477. [Google Scholar] [CrossRef]
- Fujita, M.; Shiku, H. Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I tax gene or cellular nuclear oncogenes. Oncogene 1995, 11, 15–20. [Google Scholar]
- Kao, S.Y.; Lemoine, F.J.; Mariott, S.J. HTLV-1 Tax protein sensitizes cells to apoptotic cell death induced by DNA damaging agents. Oncogene 2000, 19, 2240–2248. [Google Scholar] [CrossRef] [PubMed]
- Yamada, T.; Yamaoka, S.; Goto, T.; Nakai, M.; Tsujimoto, Y.; Hatanaka, M. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J. Virol. 1994, 68, 3374–3379. [Google Scholar] [CrossRef] [PubMed]
- Brauweiler, A.; Garrus, J.E.; Reed, J.C.; Nyborg, J.K. Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells. Virology 1997, 231, 135–140. [Google Scholar] [CrossRef] [PubMed]
- Jeang, K.T. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: Cellular signaling through NF-kappa B. Cytokine Growth Factor Rev. 2001, 12, 207–217. [Google Scholar] [CrossRef] [PubMed]
- Kawakami, A.; Nakashima, T.; Sakai, H.; Urayama, S.; Yamasaki, S.; Hida, A.; Tsuboi, M.; Nakamura, H.; Ida, H.; Migita, K.; Kawabe, Y.; Eguchi, K. Inhibition of caspase cascade by HTLV-I tax through induction of NF-kappaB nuclear translocation. Blood 1999, 94, 3847–3854. [Google Scholar] [CrossRef]
- Mulloy, J.C.; Kislyakova, T.; Cereseto, A.; Casareto, L.; LoMonico, A.; Fullen, J.; Lorenzi, M.V.; Cara, A.; Nicot, C.; Giam, C.; Franchini, G. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53- induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 1998, 72, 8852–8860. [Google Scholar] [CrossRef]
- Saggioro, D.; Barp, S.; Chieco-Bianchi, L. Block of a mitochondrial-mediated apoptotic pathway in Tax-expressing murine fibroblasts. Exp. Cell Res. 2001, 269, 245–255. [Google Scholar] [CrossRef]
- Saggioro, D.; Silic-Benussi, M.; Biasiotto, R.; D'Agostino, D.M.; Ciminale, V. Control of cell death pathways by HTLV-1 proteins. Front. Biosci. 2009, 14, 3338–3351. [Google Scholar] [CrossRef]
- Trevisan, R.; Daprai, L.; Paloschi, L.; Vajente, N.; Chieco-Bianchi, L.; Saggioro, D. Antiapoptotic effect of human T-cell leukemia virus type 1 tax protein correlates with its creb transcriptional activity. Exp. Cell Res. 2006, 312, 1390–1400. [Google Scholar] [CrossRef]
- Tsukahara, T.; Kannagi, M.; Ohashi, T.; Kato, H.; Arai, M.; Nunez, G.; Iwanaga, Y.; Yamamoto, N.; Ohtani, K.; Nakamura, M.; Fujii, M. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J. Virol. 1999, 73, 7981–7987. [Google Scholar] [CrossRef]
- Waldele, K.; Silbermann, K.; Schneider, G.; Ruckes, T.; Cullen, B.R.; Grassmann, R. Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood 2006, 107, 4491–4499. [Google Scholar] [CrossRef]
- Pise-Masison, C.A.; Radonovich, M.; Mahieux, R.; Chatterjee, P.; Whiteford, C.; Duvall, J.; Guillerm, C.; Gessain, A.; Brady, J.N. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res. 2002, 62, 3562–3571. [Google Scholar]
- de la Fuente, C.; Wang, L.; Wang, D.; Deng, L.; Wu, K.; Li, H.; Stein, L.D.; Denny, T.; Coffman, F.; Kehn, K.; et al. Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells. Mol. Cell. Biochem. 2003, 245, 99–113. [Google Scholar] [CrossRef]
- Brasier, A.R. The NF-kappaB regulatory network. Cardiovasc. Toxicol. 2006, 6, 111–130. [Google Scholar] [CrossRef]
- Sun, S.C.; Ballard, D.W. Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: Hijacking cellular IkappaB kinases. Oncogene 1999, 18, 6948–6958. [Google Scholar] [CrossRef]
- Peloponese, J.M.; Yeung, M.L.; Jeang, K.T. Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol. Res. 2006, 34, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Iha, H.; Kibler, K.V.; Yedavalli, V.R.; Peloponese, J.M.; Haller, K.; Miyazato, A.; Kasai, T.; Jeang, K.T. Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: Implications for stimulus-specific interruption of oncogenic signaling. Oncogene 2003, 22, 8912–8923. [Google Scholar] [CrossRef] [PubMed]
- Lacoste, J.; Petropoulos, L.; Pepin, N.; Hiscott, J. Constitutive phosphorylation and turnover of I kappa B alpha in human T-cell leukemia virus type I-infected and Tax-expressing T cells. J. Virol. 1995, 69, 564–569. [Google Scholar] [CrossRef] [PubMed]
- Mukherjee, S.; Negi, V.S.; Keitany, G.; Tanaka, Y.; Orth, K. In vitro activation of the IkappaB kinase complex by human T-cell leukemia virus type-1 Tax. J. Biol. Chem. 2008, 283, 15127–15133. [Google Scholar] [CrossRef] [PubMed]
- Harhaj, E.W.; Sun, S.C. IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J. Biol. Chem. 1999, 274, 22911–22914. [Google Scholar] [CrossRef]
- Harhaj, E.W.; Good, L.; Xiao, G.; Uhlik, M.; Cvijic, M.E.; Rivera-Walsh, I.; Sun, S.C. Somatic mutagenesis studies of NF-kappa B signaling in human T cells: Evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 2000, 19, 1448–1456. [Google Scholar] [CrossRef]
- Claudio, E.; Brown, K.; Siebenlist, U. NF-kappaB guides the survival and differentiation of developing lymphocytes. Cell Death Differ. 2006, 13, 697–701. [Google Scholar] [CrossRef]
- Xiao, G.; Cvijic, M.E.; Fong, A.; Harhaj, E.W.; Uhlik, M.T.; Waterfield, M.; Sun, S.C. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: Evidence for the involvement of IKKalpha. EMBO J. 2001, 20, 6805–6815. [Google Scholar] [CrossRef]
- Xiao, G.; Harhaj, E.W.; Sun, S.C. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 2001, 7, 401–409. [Google Scholar] [CrossRef]
- Hayden, M.S.; Ghosh, S. Signaling to NF-kappaB. Genes Dev. 2004, 18, 2195–2224. [Google Scholar] [CrossRef]
- Suzuki, T.; Hirai, H.; Yoshida, M. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription. Oncogene 1994, 9, 3099–3105. [Google Scholar]
- Bex, F.; McDowall, A.; Burny, A.; Gaynor, R. The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J. Virol. 1997, 71, 3484–3497. [Google Scholar] [CrossRef]
- Lamsoul, I.; Lodewick, J.; Lebrun, S.; Brasseur, R.; Burny, A.; Gaynor, R.B.; Bex, F. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol. Cell Biol. 2005, 25, 10391–10406. [Google Scholar] [CrossRef]
- Nasr, R.; Chiari, E.; El-Sabban, M.; Mahieux, R.; Kfoury, Y.; Abdulhay, M.; Yazbeck, V.; Hermine, O.; de The, H.; Pique, C.; Bazarbachi, A. Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. Blood 2006, 107, 4021–4029. [Google Scholar] [CrossRef]
- Kitajima, I.; Shinohara, T.; Bilakovics, J.; Brown, D.A.; Xu, X.; Nerenberg, M. Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-kappa B. Science 1993, 259, 1523. [Google Scholar] [CrossRef]
- Sanda, T.; Asamitsu, K.; Ogura, H.; Iida, S.; Utsunomiya, A.; Ueda, R.; Okamoto, T. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor. Leukemia 2006, 20, 590–598. [Google Scholar] [CrossRef] [PubMed]
- Mori, N.; Yamada, Y.; Ikeda, S.; Yamasaki, Y.; Tsukasaki, K.; Tanaka, Y.; Tomonaga, M.; Yamamoto, N.; Fujii, M. Bay 11–7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002, 100, 1828–1834. [Google Scholar] [CrossRef] [PubMed]
- Ohsugi, T.; Horie, R.; Kumasaka, T.; Ishida, A.; Ishida, T.; Yamaguchi, K.; Watanabe, T.; Umezawa, K.; Urano, T. In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia. Carcinogenesis 2005, 26, 1382–1388. [Google Scholar] [CrossRef] [PubMed]
- Lim, K.H.; Counter, C.M. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance. Cancer Cell 2005, 8, 381–392. [Google Scholar] [CrossRef]
- Castellano, E.; Downward, J. Role of RAS in the regulation of PI 3-kinase. Curr. Top. Microbiol. Immunol. 2011, 346, 143–169. [Google Scholar]
- Nicholson, K.M.; Anderson, N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 2002, 14, 381–395. [Google Scholar] [CrossRef]
- Datta, S.R.; Brunet, A.; Greenberg, M.E. Cellular survival: A play in three Akts. Genes Dev. 1999, 13, 2905–2927. [Google Scholar] [CrossRef]
- Kane, L.P.; Shapiro, V.S.; Stokoe, D.; Weiss, A. Induction of NF-kappaB by the Akt/PKB kinase. Curr. Biol. 1999, 9, 601–604. [Google Scholar] [CrossRef]
- Gustin, J.A.; Korgaonkar, C.K.; Pincheira, R.; Li, Q.; Donner, D.B. Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52. J. Biol. Chem. 2006, 281, 16473–16481. [Google Scholar] [CrossRef]
- Du, K.; Montminy, M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 1998, 273, 32377–32379. [Google Scholar] [CrossRef]
- Fresno Vara, J.A.; Casado, E.; de Castro, J.; Cejas, P.; Belda-Iniesta, C.; Gonzalez-Baron, M. PI3K/Akt signalling pathway and cancer. Cancer Treat. Rev. 2004, 30, 193–204. [Google Scholar] [CrossRef]
- Maehama, T.; Dixon, J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 1998, 273, 13375–13378. [Google Scholar] [CrossRef]
- Taylor, V.; Wong, M.; Brandts, C.; Reilly, L.; Dean, N.M.; Cowsert, L.M.; Moodie, S.; Stokoe, D. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol. Cell. Biol. 2000, 20, 6860–6871. [Google Scholar] [CrossRef]
- Jeong, S.J.; Pise-Masison, C.A.; Radonovich, M.F.; Park, H.U.; Brady, J.N. Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 2005, 24, 6719–6728. [Google Scholar] [CrossRef]
- Ikezoe, T.; Nishioka, C.; Bandobashi, K.; Yang, Y.; Kuwayama, Y.; Adachi, Y.; Takeuchi, T.; Koeffler, H.P.; Taguchi, H. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk. Res. 2007, 31, 673–682. [Google Scholar] [CrossRef]
- Liu, Y.; Wang, Y.; Yamakuchi, M.; Masuda, S.; Tokioka, T.; Yamaoka, S.; Maruyama, I.; Kitajima, I. Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax. Oncogene 2001, 20, 2514–2526. [Google Scholar] [CrossRef]
- Peloponese, J.M., Jr.; Jeang, K.T. Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J. Biol. Chem. 2006, 281, 8927–8938. [Google Scholar] [CrossRef]
- Fukuda, R.I.; Tsuchiya, K.; Suzuki, K.; Itoh, K.; Fujita, J.; Utsunomiya, A.; Tsuji, T. Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-kappaB pathway. J. Biol. Chem. 2009, 284, 2680–2689. [Google Scholar] [CrossRef]
- Jeong, S.J.; Dasgupta, A.; Jung, K.J.; Um, J.H.; Burke, A.; Park, H.U.; Brady, J.N. PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology 2008, 370, 264–272. [Google Scholar] [CrossRef]
- Mayr, B.; Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2001, 2, 599–609. [Google Scholar] [CrossRef]
- Conkright, M.D.; Canettieri, G.; Screaton, R.; Guzman, E.; Miraglia, L.; Hogenesch, J.B.; Montminy, M. TORCs: transducers of regulated CREB activity. Mol. Cell 2003, 12, 413–423. [Google Scholar] [CrossRef] [PubMed]
- Altarejos, J.Y.; Montminy, M. CREB and the CRTC co-activators: Sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 2011, 12, 141–151. [Google Scholar] [CrossRef] [PubMed]
- Sakamoto, K.M.; Frank, D.A. CREB in the pathophysiology of cancer: Implications for targeting transcription factors for cancer therapy. Clin. Cancer Res. 2009, 15, 2583–2587. [Google Scholar] [CrossRef] [PubMed]
- Wen, A.Y.; Sakamoto, K.M.; Miller, L.S. The role of the transcription factor CREB in immune function. J. Immunol. 2010, 185, 6413–6419. [Google Scholar] [CrossRef]
- Baumann, S.; Kyewski, B.; Bleckmann, S.C.; Greiner, E.; Rudolph, D.; Schmid, W.; Ramsay, R.G.; Krammer, P.H.; Schutz, G.; Mantamadiotis, T. CREB function is required for normal thymic cellularity and post-irradiation recovery. Eur. J. Immunol. 2004, 34, 1961–1971. [Google Scholar] [CrossRef]
- Cheng, J.C.; Kinjo, K.; Judelson, D.R.; Chang, J.; Wu, W.S.; Schmid, I.; Shankar, D.B.; Kasahara, N.; Stripecke, R.; Bhatia, R.; et al. CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Blood 2008, 111, 1182–1192. [Google Scholar] [CrossRef]
- Ciani, E.; Guidi, S.; Della Valle, G.; Perini, G.; Bartesaghi, R.; Contestabile, A. Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation. J. Biol. Chem. 2002, 277, 49896–49902. [Google Scholar] [CrossRef]
- Jean, D.; Harbison, M.; McConkey, D.J.; Ronai, Z.; Bar-Eli, M. CREB and its associated proteins act as survival factors for human melanoma cells. J. Biol. Chem. 1998, 273, 24884–24890. [Google Scholar] [CrossRef]
- Shankar, D.B.; Cheng, J.C.; Kinjo, K.; Federman, N.; Moore, T.B.; Gill, A.; Rao, N.P.; Landaw, E.M.; Sakamoto, K.M. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 2005, 7, 351–362. [Google Scholar] [CrossRef]
- Shankar, D.B.; Cheng, J.C.; Sakamoto, K.M. Role of cyclic AMP response element binding protein in human leukemias. Cancer 2005, 104, 1819–1824. [Google Scholar] [CrossRef]
- Aggarwal, S.; Kim, S.W.; Ryu, S.H.; Chung, W.C.; Koo, J.S. Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein. Cancer Res. 2008, 68, 981–988. [Google Scholar] [CrossRef]
- Cho, Y.S.; Kim, M.K.; Cheadle, C.; Neary, C.; Park, Y.G.; Becker, K.G.; Cho-Chung, Y.S. A genomic-scale view of the cAMP response element-enhancer decoy: A tumor target-based genetic tool. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 15626–15631. [Google Scholar] [CrossRef]
- Park, Y.G.; Nesterova, M.; Agrawal, S.; Cho-Chung, Y.S. Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth. J. Biol. Chem. 1999, 274, 1573–1580. [Google Scholar] [CrossRef]
- Siu, Y.T.; Chin, K.T.; Siu, K.L.; Yee Wai Choy, E.; Jeang, K.T.; Jin, D.Y. TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J. Virol. 2006, 80, 7052–7059. [Google Scholar] [CrossRef] [PubMed]
- Kim, Y.M.; Geiger, T.R.; Egan, D.I.; Sharma, N.; Nyborg, J.K. The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription. Oncogene 2010, 29, 2142–2152. [Google Scholar] [CrossRef]
- Hishiki, T.; Ohshima, T.; Ego, T.; Shimotohno, K. BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3. J. Biol. Chem. 2007, 282, 28335–28343. [Google Scholar] [CrossRef]
- Jiang, S.; Inada, T.; Tanaka, M.; Furuta, R.A.; Shingu, K.; Fujisawa, J. Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1. Retrovirology 2009, 6, 73. [Google Scholar] [CrossRef]
- Trevisan, R.; Daprai, L.; Acquasaliente, L.; Ciminale, V.; Chieco-Bianchi, L.; Saggioro, D. Relevance of CREB phosphorylation in the anti-apoptotic function of human T-lymphotropic virus type 1 tax protein in serum-deprived murine fibroblasts. Exp. Cell Res. 2004, 299, 57–67. [Google Scholar] [CrossRef]
- Kim, Y.M.; Ramirez, J.A.; Mick, J.E.; Giebler, H.A.; Yan, J.P.; Nyborg, J.K. Molecular characterization of the tax-containing HTLV-1 enhancer complex reveals a prominent role for CREB phosphorylation in tax transactivation. J. Biol. Chem. 2007, 282, 18750–18757. [Google Scholar] [CrossRef]
- Vajente, N.; Trevisan, R.; Saggioro, D. HTLV-1 Tax protein cooperates with Ras in protecting cells from apoptosis. Apoptosis 2009, 14, 153–163. [Google Scholar] [CrossRef]
- Nonaka, M.; Uota, S.; Saitoh, Y.; Takahashi, M.; Sugimoto, H.; Amet, T.; Arai, A.; Miura, O.; Yamamoto, N.; Yamaoka, S. Role for protein geranylgeranylation in adult T-cell leukemia cell survival. Exp. Cell Res. 2009, 315, 141–150. [Google Scholar] [CrossRef] [PubMed]
- Gu, T.; Zhang, Z.; Wang, J.; Guo, J.; Shen, W.H.; Yin, Y. CREB is a novel nuclear target of PTEN phosphatase. Cancer Res. 2011, 71, 2821–2825. [Google Scholar] [CrossRef] [PubMed]
© 2011 by the author. licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Saggioro, D. Anti-Apoptotic Effect of Tax: An NF-κB Path or a CREB Way? Viruses 2011, 3, 1001-1014. https://doi.org/10.3390/v3071001
Saggioro D. Anti-Apoptotic Effect of Tax: An NF-κB Path or a CREB Way? Viruses. 2011; 3(7):1001-1014. https://doi.org/10.3390/v3071001
Chicago/Turabian StyleSaggioro, Daniela. 2011. "Anti-Apoptotic Effect of Tax: An NF-κB Path or a CREB Way?" Viruses 3, no. 7: 1001-1014. https://doi.org/10.3390/v3071001